Cargando…
Promoting access to COVID-19 convalescent plasma in low- and middle-income countries
Low- and middle-income countries (LMICs) remain neglected in the Coronavirus 19 (COVID-19) pandemic. COVID-19 convalescent plasma (CCP) (i.e. plasma collected from individuals after their recovery from COVID-19) has emerged as a leading medical treatment for COVID-19. Studies to date support the saf...
Autores principales: | Bloch, Evan M., Goel, Ruchika, Montemayor, Celina, Cohn, Claudia, Tobian, Aaron A.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502258/ https://www.ncbi.nlm.nih.gov/pubmed/32972861 http://dx.doi.org/10.1016/j.transci.2020.102957 |
Ejemplares similares
-
COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022) -
Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020) -
Sequential dosing of convalescent COVID-19 plasma with significant temporal clinical improvements in a persistently SARS-COV-2 positive patient
por: Mirihagalle, Noupama, et al.
Publicado: (2021) -
Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer
por: Bloch, Evan M, et al.
Publicado: (2021) -
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023)